CIITECH, a UK-Israel cannabis biotech startup that seeks to develop and commercialize therapeutic cannabis products, said it would fund a research project together with the Hebrew University of Jerusalem to find ways to use cannabis for the treatment of asthma.
CIITECH said the project would be undertaken by the Multidisciplinary Center on Cannabinoid Research of the Hebrew University, and would be led by Prof. Raphael Mechoulam, a pioneer in the field of cannabis research, and his colleague, Prof. Francesca Levi-Schaffer, who specializes in asthma research. The project was selected through a competition, from among a dozen other projects proposed on cannabis research, said CIITECH founder Clifton Flack. CONTENT CREDIT: CBD Project
Share on Facebook
Share on Twitter
I'm busy working on my blog posts. Watch this space!